Michael Q. Kemp. 1550 WoodbrookDrive, Apartment 20,East Lansing, MI, 48823. 2000 TO 2005PhDin Nutritional Sciences with a minor in Cancer Biology, 4.0 cumulative GPA, University of Arizona, Tucson, AZ (Expected completion date 5/2005).
Alkylating chemotherapeutic agentscyclophosphamide and melphalan cause functional injury to human bone marrow-derived mesenchymal stem cells. Dr Kevin Kemp, Dr Ruth Morse, Dr Kelly Sanders,Professor Jill Hows, Dr Craig Donaldson. Centre for Research in Biomedicine, Faculty of Applied Sciences.
Note: This checklist must be included in IRB Submission. DUHS IRB Protocol Submission Checklist. Departmental or CRU Review. PI: Check: New Review OR Renewal. Required elements prior to submission for IRB review. Reviewer s Comments. Investigator s Response.
For sponsored trials, proper documentation of sponsor acknowledgement and/or approval for each deviation is required and must be attached to the log. If 3 or more minor deviations/violations of the same type (or for the same subject) are found in the.
ESETT / Philadelphia Area Before Study Start EFIC Report. Established Status Epilepticus Treatment Trial. Exception from Informed Consent. Philadelphia Areabefore Study Start EFIC Report. National Institute for Neurological Disorders and Stroke. Project Number: 1 U01 NS088034 01.
This guidanceoutlines the additional obligations of investigators conducting a <Clinical Trial> Investigator's Qualifications and Agreements. The investigator(s) should be qualified by education, training, and experience to assume responsibility.
Colorado Multiple Institutional Review Board. *Please contact the COMIRB before using this form: 303-724-1055. This form must be completed for each person who will be treated with the investigational device. PLEASE NOTE THAT THIS FORM CANNOT BE USED FOR DRUGS.
Clinical trial essentialsfor medical imagers. Sponsoring Organizations. Radiological Society of North America, Oak Brook, IL. National Cancer Institute, NIH, Bethesda, MD. Compiled and edited by. C. Carl Jaffe, M.D. NCI. Click here for 2011 full participating faculty list.
NUS Institutional Review Board (IRB). APPLICATION FORM. I acknowledge that this research is in keeping with standards set by the Principal Investigator s department. *The Head of Department can be the Head / Chief of the PI s Department.
Study Sets Standards for Evaluating Pluripotent Stem Cell Quality. Transformative Technology Not Quite Ready for Clinical Use. CINCINNATI, June 9, 2016 /PRNewswire-USNewswire. As the promise of using regenerative stem cell therapies draws closer, a consortium.
Motivation, Perception, and Treatment Beliefs in the Myocardial Infarction Genes (MI-GENES) Randomized Clinical Trial. Sharma Kattel1*, Tochukwu Onyekwelu2*, Sherry-Ann Brown1, Hayan Jouni1, Erin E. Austin1, Iftikhar J Kullo1. Short Title: Motivation, perception and treatment beliefs in MI GENES.
Stem Cell Project Due 3/17/10. Stem cells are undifferentiated cells that have the ability change into specialized cells. Research is being done to see if stem cells can be used to treat disorders or replace tissue or organs that are injured or diseased.These.
Sponsored Research. VI.1 Sponsored Research. Sponsored Research. Sponsored Research.
SIG Strategic Goals 2012 - 2016. Agreed Upon SIG Goals. Develop basic and advanced content materials for members based on Needs Assessment survey. Submit 5 questions for annual needs assessment survey. (ongoing). Conduct SIG Specific Needs assessment every 3 years, (next 2014).
New Global HealthClinical and Research opportunities announcing the UMMS partnership with the Academic Model Providing Access to Healthcare (AMPATH) Consortium in Eldoret, Kenya. What is AMPATH?
Research Style: IIE Transactions. Thesis Proposal. Evaluating and Enhancing Response to an Aerosolized Anthrax Attack in the Washington, DC Metropolitan Area. KYLE JAMOLIN, JONATHAN SALTZMAN, DARRELL SCHAEFER, SEBASTIAN SERRANO, AARON SHIM and JOSHUA SLOANE. Mentor: Dr. Jeffrey Herrmann - YES.